Key facts
- This page summarizes Ho Jien Shiung's Form 3 filing for Cyclacel Pharmaceuticals, Inc. (CYCC).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 15 May 2025, 14:39.
Ho Jien Shiung - 29 Apr 2025 Form 3 Insider Report for Cyclacel Pharmaceuticals, Inc. (CYCC)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- CYCC
- Reported as of
- 29 Apr 2025
- Net transaction value
- $0
- Reporting owner signature
- /s/ Ho Jien Shiung
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Ho Jien Shiung filed Form 3 for Cyclacel Pharmaceuticals, Inc. (CYCC) on 15 May 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002068628
Primary reporting owner
Ho Jien Shiung
- Relationship
- 10%+ Owner
- Address
- LEVEL 10, TOWER 11,, AVENUE 5, NO. 8, JALAN KERINCHI, KUALA LUMPUR,, MALAYSIA
- Signature
- /s/ Ho Jien Shiung
- Signature date
- 15 May 2025
This filing has been restated.
Open the amended filing.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CYCC
holding
Cyclacel Common Stock, par value $0.0001 per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 250,000
- Date
- 29 Apr 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.